AMSTERDAM and GENEVA, May 16, 2023 /PRNewswire/ iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer, today announces the
MyJournals.org - Science - IJMS, Vol. 24, Pages 8462: Pulmonary Hypertension: New Insights and Recent Advances from Basic Science to Translational Approaches (International Journal of Molecular Sciences)
New translational and clinical biomarker data from Zai Lab’s global oncology program ZL-1211 will be featured in a poster presentation SHANGHAI and CAMBRIDGE, Mass., April 11, 2023 Zai Lab. | April 11, 2023
NanoString Technologies, Inc. , a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel. | March 1, 2023
NanoString Technologies, Inc. , a leading provider of life science tools for discovery and translational research, today announced that the Company will report fourth quarter and fiscal year 2022. | February 14, 2023